RET and medullary thyroid gland carcinoma: From a molecular perspective, in vitro and in vivo studies on mouse models demonstrated that, besides the robust MET and VEGFR2 antagonism, CBZ inhibits both the wild type and the mutated forms of RET, preventing MTC cells and xenograft from growing and metastasising [19].